Correlation Between Stoke Therapeutics and Neurobo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Neurobo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Neurobo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stoke Therapeutics and Neurobo Pharmaceuticals, you can compare the effects of market volatilities on Stoke Therapeutics and Neurobo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Neurobo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Neurobo Pharmaceuticals.
Diversification Opportunities for Stoke Therapeutics and Neurobo Pharmaceuticals
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Stoke and Neurobo is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Neurobo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobo Pharmaceuticals and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Neurobo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobo Pharmaceuticals has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Neurobo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Stoke Therapeutics and Neurobo Pharmaceuticals
Given the investment horizon of 90 days Stoke Therapeutics is expected to generate 0.83 times more return on investment than Neurobo Pharmaceuticals. However, Stoke Therapeutics is 1.21 times less risky than Neurobo Pharmaceuticals. It trades about -0.04 of its potential returns per unit of risk. Neurobo Pharmaceuticals is currently generating about -0.16 per unit of risk. If you would invest 1,231 in Stoke Therapeutics on August 27, 2024 and sell it today you would lose (53.00) from holding Stoke Therapeutics or give up 4.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Stoke Therapeutics vs. Neurobo Pharmaceuticals
Performance |
| Timeline |
| Stoke Therapeutics |
| Neurobo Pharmaceuticals |
Stoke Therapeutics and Neurobo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Stoke Therapeutics and Neurobo Pharmaceuticals
The main advantage of trading using opposite Stoke Therapeutics and Neurobo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Neurobo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will offset losses from the drop in Neurobo Pharmaceuticals' long position.| Stoke Therapeutics vs. Adaptimmune Therapeutics Plc | Stoke Therapeutics vs. Black Diamond Therapeutics | Stoke Therapeutics vs. Relay Therapeutics | Stoke Therapeutics vs. Pliant Therapeutics |
| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |